KRAS inhibitors in drug resistance and potential for combination therapy
Tumori Journal · 2025
DOI: 10.1177/03008916241289206 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Tumori Journal, 2025. Verfasst von Lala S Rathod und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins p21(ras), Drug Resistance, Neoplasm, Antineoplastic Combined Chemotherapy Protocols, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 124 Literaturangaben.
Abstract (Originalsprache)
Kirsten Rat Sarcoma (KRAS) is a potent target for cancer therapy because it acts as a signaling hub, engaging in various signaling pathways and regulating a number of cellular functions like cell differentiation, proliferation, and survival. Recently, an emergency approval from the US-FDA has been issued for KRAS G12C inhibitors (sotorasib and adagrasib) for metastatic lung cancer treatment. However, clinical studies on covalent KRAS G12C inhibitors have rapidly confronted resistance in patients. Many methods are being assessed to overcome this resistance, along with various combinatorial clinical studies that are in process. Moreover, because KRAS G12D and KRAS G12V are more common than KRAS G12C , focus must be placed on the therapeutic strategies for this type of patient, along with sustained efforts in research on these targets. In the present review, we try to focus on various strategies to overcome rapid resistance through the use of combinational treatments to improve the activity of KRAS G12C inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
ORCID-Profile: Santosh N Mokale
Zitieren
APA
Rathod, L. S., Sakle, N. S., & Mokale, S. N. (2025). KRAS inhibitors in drug resistance and potential for combination therapy. Tumori Journal. https://doi.org/10.1177/03008916241289206
Vancouver
Rathod LS, Sakle NS, Mokale SN. KRAS inhibitors in drug resistance and potential for combination therapy. Tumori Journal. 2025. doi:10.1177/03008916241289206
BibTeX
@article{Rathod2025,
author = {Rathod, Lala S and Sakle, Nikhil S and Mokale, Santosh N},
title = {KRAS inhibitors in drug resistance and potential for combination therapy},
journal = {Tumori Journal},
year = {2025},
doi = {10.1177/03008916241289206}
}
EUVIMED